Filing Flows › United Guardian (UG) › Q2 2026 › vs Q2 2025
United Guardian (UG) Q2 2026 vs Q2 2025 (year over year)
United Guardian's revenue rose $270K (+10%) from $2.8M in Q2 2025 to $3.1M in Q2 2026. The biggest changes: Cosmetic Ingredients +$390K (+44%); Medical −$137K (-28%); Pharmaceuticals +$17K (+1%). Operating margin 24.3% against 24.5% (-0.2 pts).
United Guardian, Q2 2026: revenue $3.1M (+10% year over year), operating margin 24.3%, net earnings $729K, operating cash flow $1.5M. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Operating margin | 24.3% | 24.5% | -0.2 pts |
| Net margin | 23.4% | 22.1% | +1.4 pts |
| Free cash flow margin | 48.3% | 10.1% | +38.2 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Pharmaceuticals | $1.5M | $1.5M | $17K | +1% |
| Cosmetic Ingredients | $1.3M | $897K | $390K | +44% |
| Medical | $353K | $490K | −$137K | -28% |
| Revenue | $3.1M | $2.8M | $270K | +10% |
| Other income, net | $163K | $95K | $68K | +72% |
| Operating profit | $754K | $695K | $59K | +8% |
| Costs & expenses | $2.4M | $2.1M | $211K | +10% |
| Pre-tax earnings | $918K | $791K | $127K | +16% |
| Cost of revenue | $1.6M | $1.3M | $222K | +17% |
| Research & development | $124K | $108K | $17K | +15% |
| Other operating costs | $667K | $694K | −$27K | -4% |
| Net earnings | $729K | $627K | $102K | +16% |
| Income tax | $189K | $164K | $25K | +15% |
| Depreciation & amortization | $29K | $25K | $4K | +17% |
| Working capital & other | $762K | −$349K | $1.1M | — |
| Operating cash flow | $1.5M | $303K | $1.2M | +401% |
| Free cash flow (OCF − capex) | $1.5M | $286K | $1.2M | +425% |
| Capital expenditures | $19K | $18K | $2K | +9% |
Questions
How much did United Guardian's revenue grow year over year in Q2 2026?
United Guardian's revenue rose $270K (+10%) from $2.8M in Q2 2025 to $3.1M in Q2 2026.
What drove United Guardian's revenue change in Q2 2026?
Cosmetic Ingredients +$390K (+44%); Medical −$137K (-28%); Pharmaceuticals +$17K (+1%).